Literature DB >> 9666111

Duration of neurofibrillary changes in the hippocampal pyramidal neurons.

M Bobinski1, J Wegiel, M Tarnawski, M J de Leon, B Reisberg, D C Miller, H M Wisniewski.   

Abstract

The total number of neurons with and without neurofibrillary changes in sectors CA1 to CA4, subiculum, and dentate gyrus of 16 subjects with Alzheimer disease (AD) was estimated. The duration of neurofibrillary changes was calculated on the basis of regressions between the duration of AD and neuronal numbers. In the CA1 and subiculum, it takes 3.4 and 5.4 years, respectively, for an intact neuron affected by neurofibrillary pathology to become a ghost tangle. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh：

Year:  1998        PMID： 9666111     DOI： 10.1016/s0006-8993(98)00441-7

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  13 in total

1.  Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.

Authors:  Michiyo Iba; Jennifer D McBride; Jing L Guo; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2015-07-07       Impact factor: 17.088

2.  An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Masanori Ishikawa; Hiroyasu Akatsu; Eric E Abrahamson; Milos D Ikonomovic; Takashi Asada
Journal:  Neuropathology       Date:  2011-01-27       Impact factor: 1.906

3.  Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats.

Authors:  Sara Johansson; Ann-Cathrin Radesäter; Richard F Cowburn; Johan Thyberg; Johan Luthman
Journal:  Exp Brain Res       Date:  2005-09-21       Impact factor: 1.972

Review 4.  The pathology of paraphrenia.

Authors:  Manuel F Casanova
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

5.  Serotonin 1A receptors in the living brain of Alzheimer's disease patients.

Authors:  Vladimir Kepe; Jorge R Barrio; Sung-Cheng Huang; Linda Ercoli; Prabha Siddarth; Kooresh Shoghi-Jadid; Gregory M Cole; Nagichettiar Satyamurthy; Jeffrey L Cummings; Gary W Small; Michael E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

6.  Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.

Authors:  A J Ehrenberg; A K Nguy; P Theofilas; S Dunlop; C K Suemoto; A T Di Lorenzo Alho; R P Leite; R Diehl Rodriguez; M B Mejia; U Rüb; J M Farfel; R E de Lucena Ferretti-Rebustini; C F Nascimento; R Nitrini; C A Pasquallucci; W Jacob-Filho; B Miller; W W Seeley; H Heinsen; L T Grinberg
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-31       Impact factor: 8.090

7.  Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease.

Authors:  Jerzy Wegiel; Michael Flory; Izabela Kuchna; Krzysztof Nowicki; Shuang Yong Ma; Jarek Wegiel; Eulalia Badmaev; Mony de Leon; Thomas Wisniewski; Barry Reisberg
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-01       Impact factor: 3.685

Review 8.  Plasticity and the spread of Alzheimer's disease-like changes.

Authors:  Thomas G Ohm; Frauke Glöckner; Roland Distl; Stefanie Treiber-Held; Volker Meske; Bärbel Schönheit
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

9.  Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Kenneth N Fish; Milos D Ikonomovic; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.

Authors:  Christy M Kelley; Sylvia E Perez; Cassia R Overk; David Wynick; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.